129 related articles for article (PubMed ID: 8116080)
1. Plasma D-dimer measurement as a marker of gynecologic tumors: comparison with Ca 125.
Rella C; Coviello M; De Frenza N; Falco G; Chiuri E; Colavito P; Quaranata M; De Leonardis A
Tumori; 1993 Oct; 79(5):347-51. PubMed ID: 8116080
[TBL] [Abstract][Full Text] [Related]
2. Measurement of crosslinked fibrin derivatives in plasma and ascitic fluid with monoclonal antibodies against D dimer using EIA and latex test.
Hafter R; Schröck R; von Hugo R; Graeff H
Scand J Clin Lab Invest Suppl; 1985; 178():137-44. PubMed ID: 3867114
[TBL] [Abstract][Full Text] [Related]
3. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H
Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
[TBL] [Abstract][Full Text] [Related]
4. The measurement of plasma D-dimer (DD) levels in the follow-up of patients with ovarian cancer.
Gadducci A; Marrai R; Baicchi U; Ferdeghini M; Fanucchi A; Facchini V; Genazzani AR
Anticancer Res; 1995; 15(6B):2683-6. PubMed ID: 8669847
[TBL] [Abstract][Full Text] [Related]
5. Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses.
Gadducci A; Baicchi U; Marrai R; Ferdeghini M; Bianchi R; Facchini V
Gynecol Oncol; 1996 Feb; 60(2):197-202. PubMed ID: 8631538
[TBL] [Abstract][Full Text] [Related]
6. Plasma D-dimer and peritoneal CA-125 levels as predictors of disease status in ovarian carcinoma.
Rose PG; Terrien JM; Baker S
J Surg Oncol; 1994 Jul; 56(3):168-71. PubMed ID: 8028348
[TBL] [Abstract][Full Text] [Related]
7. Preoperative plasma D-dimer level is a useful prognostic marker in ovarian cancer.
Yamada Y; Kawaguchi R; Iwai K; Niiro E; Morioka S; Tanase Y; Kobayashi H
J Obstet Gynaecol; 2020 Jan; 40(1):102-106. PubMed ID: 31335252
[TBL] [Abstract][Full Text] [Related]
8. D-dimer, Fibrinogen and Tumor Marker Levels in Patients with benign and Malignant Ovarian Tumors.
Farzaneh F; Salimnezhad M; Hosseini MS; Ashraf Ganjouee T; Arab M; Talayeh M
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4263-4268. PubMed ID: 38156862
[TBL] [Abstract][Full Text] [Related]
9. D-dimer and CA 125 levels in patients with ovarian cancer during antineoplastic therapy. Prognostic significance for the success of anti-cancer treatment.
Mirshahi SS; Pujade-Lauraine E; Soria C; Mirshahi M; Fretault J; Bernadou A; Soria J
Cancer; 1992 May; 69(9):2289-92. PubMed ID: 1562974
[TBL] [Abstract][Full Text] [Related]
10. [Simultaneous determination of Ca 125 and D-dimer in plasma and ascites in ovarian cancer].
Schröck R; Hafter R; Graeff H; Schmid L
Onkologie; 1985 Oct; 8(5):260-2. PubMed ID: 2999668
[TBL] [Abstract][Full Text] [Related]
11. D-dimer as a tumor marker in pre-operative assessment of adnexal masses.
Worasethsin P; Narkwichean A
J Med Assoc Thai; 2013 Nov; 96(11):1395-400. PubMed ID: 24428087
[TBL] [Abstract][Full Text] [Related]
12. [Tumor marker CA 72-4 in ovarian cancer in comparison with CA 125 and D-dimer].
Schelling M; Jänicke F; Senekowitsch R; Lörken A
Gynakol Rundsch; 1991; 31 Suppl 2():286-9. PubMed ID: 1665138
[No Abstract] [Full Text] [Related]
13. [The role of D-dimer in diagnosis of ovarian cancer].
Kanayama N
Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):485-8. PubMed ID: 2056222
[TBL] [Abstract][Full Text] [Related]
14. Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications.
Chen W; Zhong S; Shan B; Zhou S; Wu X; Yang H; Ye S
J Ovarian Res; 2020 Aug; 13(1):89. PubMed ID: 32771026
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors.
Lenhard MS; Nehring S; Nagel D; Mayr D; Kirschenhofer A; Hertlein L; Friese K; Stieber P; Burges A
Clin Chem Lab Med; 2009; 47(5):537-42. PubMed ID: 19317653
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of plasma D-dimer levels in patients with lung cancer.
Taguchi O; Gabazza EC; Yasui H; Kobayashi T; Yoshida M; Kobayashi H
Thorax; 1997 Jun; 52(6):563-5. PubMed ID: 9227726
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of plasma D-dimer in ovarian cancer: A meta-analysis.
Wu J; Fu Z; Liu G; Xu P; Xu J; Jia X
Medicine (Baltimore); 2017 Jun; 96(25):e7062. PubMed ID: 28640083
[TBL] [Abstract][Full Text] [Related]
18. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.
Claussen C; Rausch AV; Lezius S; Amirkhosravi A; Davila M; Francis JL; Hisada YM; Mackman N; Bokemeyer C; Schmalfeldt B; Mahner S; Langer F
Thromb Res; 2016 May; 141():39-48. PubMed ID: 26967531
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of serum sialosyl-Tn antigen levels in comparison with CA 125 levels in gynecologic cancers.
Ryuko K; Iwanari O; Nakayama S; Iida K; Kitao M
Cancer; 1992 May; 69(9):2368-78. PubMed ID: 1562985
[TBL] [Abstract][Full Text] [Related]
20. Preoperative D-dimer plasma assay is not a predictor of clinical outcome for patients with advanced ovarian cancer.
Gadducci A; Marrai R; Baicchi U; Ferdeghini M; Fanucchi A; Weiss C; Genazzani AR
Gynecol Oncol; 1997 Jul; 66(1):85-8. PubMed ID: 9234926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
